School of Medicine
Showing 31-40 of 48 Results
-
Abraham Verghese, MD, MACP
Linda R. Meier and Joan F. Lane Provostial Professor
Current Research and Scholarly InterestsMy interest is in clinical skills and the bedside exam, both in its technical aspects, but also in the importance of the ritual and what is conveyed by the physician's presence and technique at the bedside. This work interests me from an educational point of view, and also from the point of view of ethnographic studies related to rituals and how they transform the patient-physician relationship. Recently we have become interested in medical error as a result of oversights in the bedside exam.
-
Erika Viana Cardenas
Postdoctoral Scholar, Infectious Diseases
BioMedical Doctor passionate for public health and evidence-based decision making with experience in data management and surveillance systems in the Colombian government sector and academic research.
-
Maria Norma Villalon Landeros
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Norma Villalon's path to medicine reflects a journey of perseverance and community service. Born and raised in rural Guanajuato, Mexico, her early years were shaped by strong family bonds and a deep appreciation for community care, despite financial challenges. Before immigrating to the United States at 18, she dedicated herself to adult education through INEA, teaching literacy and basic education to members of her community. This early experience fostered her commitment to serving diverse populations and understanding their unique needs. As a first-generation professional from an immigrant background, Dr. Villalon brings a unique perspective to medicine, informed by her profound understanding of underserved communities. Her journey from a small Mexican village to becoming a physician exemplifies the power of determination and the importance of accessible healthcare. Through her work, she continues to advocate for equitable medical care while actively mentoring and supporting the next generation of physicians from underrepresented backgrounds.
-
Dr. Janaki Manoja Vinnakota
Affiliate, Medicine - Med/Oncology
Visiting Postdoctoral Scholar, Medicine - Med/OncologyBioJanaki Manoja Vinnakota PhD is a Junior Group Leader in the Department of Hematology, Oncology, and Stem Cell Transplantation at the University Medical Center Freiburg, Germany. She is a visiting post-doctoral scholar at Stanford at CCSR. Dr. Vinnakota’s research provided insights into understanding the pathomechanisms associated with central nervous system (CNS) related toxicities such as graft versus host diseases (CNS-GVHD), neurological immune related adverse events (nirAEs) and immune cell associated neurotoxicity syndrome (ICANS) and has most importantly unveiled therapeutic targets with high translational value. She identified the critical role of microglia/myeloid cells in mediating the neurotoxicity and cognitive impairment post diverse cancer immunotherapies. Her work on microglial Syk activation post immune checkpoint inhibition led to a translational application of the most promising and clinically available Syk inhibitor to target CNS irAEs. Dr. Vinnakota was awarded the highly competitive Hans A Krebs Medical Scientist grant, Germany to develop novel therapies that target CAR T cell associated toxicities.
Dr. Vinnakota holds a bachelor's and master's degree in engineering with a focus on biotechnology from IIT Madras, India. Her strong foundation in basic biology has enabled her to investigate projects with significant translational potential. For her Ph.D., Dr. Vinnakota studied the mechanisms of neurotoxicity following allogeneic stem cell transplantation and CAR T cell therapy. During her postdoctoral research, she expanded her expertise to explore neurotoxicity’s associated with immune checkpoint inhibition (anti-PD-1), the gut-microbiome axis in CNS-GVHD, and novel Kinase inhibition strategies to address GVHD.
Dr. Vinnakota was also honored with the prestigious Jan van Rood award from the EBMT society for her work on Targeting ICANS after CD19 CAR T cell therapy and she received the Prize for Innovative Research Approaches in Oncology by the Mertesmann Foundation, Germany for her groundbreaking work on the mechanisms of ICANS after CD19 CAR T cell therapy. Her contributions to immuno-oncology have been published in leading journals such as Nature Cancer, Science Translational Medicine, Journal of Clinical Investigation, and Nature Communications. Additionally, she actively mentors PhD an d MD students working on diverse cancer immunotherapy projects.
